In this case, the IP exports mostly represent American production and distribution partners paying Novo Nordisk to use the patents and other research output relevant to GLP-1 drugs
Newer GLP-1 medications available as injections and pills have proven to be highly effective for weight loss, ushering in a new era of obesity treatment
Originally characterized at the University of Florida by the Stephen ORahilly and Robert Kraft groups, the compound has been studied in preclinical research for body composition, adipose tissue lipolysis, glucose homeostasis, skeletal muscle aging, and metabolic disease endpoints
In explaining the significance of the findings, Tuttle said, We now have four pillars of therapy, and the future is likely about combining therapies, analogous to how complementary types of cancer therapies are combined
Are you finding it difficult to lose weight despite lifestyle changes